PATENT CLAIM ANALYSIS

Application Number: 16015179
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "452000"]

Abstract:
This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.

Claim (Index 1):
A nanosphere compositional structure comprising encapsulated cannabinoids in a stable nanoparticle structure of essential phospholipids, lipids and excipients; wherein the nanoparticle structure has a particle size distribution from 50 to 150 nm.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 94.0
- Lexical Diversity: 1.51471
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15103850', '15554209', '14816959', '13547039', '14312570']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7282413743012924
- 35 USC 102 Novelty (BERT): 0.5907268333276117
- Combined Prediction Score: 0.7144899202039243
- Mean Citation Score: 334.0778200000001
- Max Citation Score: 578.4836
- Similarity Product: 405.1742204995871

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test